Glaukos Announces FDA 510(k) Clearance of iPRIME™
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Day: January 6, 2022
Empower Clinics Announces Closing of C$3.0 Million Private Placement Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / January...
Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 6, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or...
Built In Honors Xealth in Its Esteemed 2022 Best Places To Work Awards
Xealth Earns 3rd Place on Built In’s Best Small Business to Work for In Seattle and 24th Overall SEATTLE--(BUSINESS WIRE)--#BestPlacestoWork--Built...
AGAPE ATP CORPORATION Announce Expansion of Personalised Wellness Solution Business
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / January 6, 2022 / AGAPE ATP CORPORATION (OTC PINK:AATP) is pleased to announce that...
Sativa Wellness Group Announces ISO 22000 Food Safety Management System Certification
VANCOUVER, BC / ACCESSWIRE / January 6, 2022 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") announced...
Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth
RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) has expanded its existing inventory line...
Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina
Supports Growth Plans in European and Latin American marketsRALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc....
Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape
“Five Ways to Attract Early-Stage Investors” identifies strategies to help biotech companies attract funding and increase their chances of delivering...
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
PacBio’s Sequel IIe devices will support genomic researchers around the worldMENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio...
Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Houston, Texas, USA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. will participate in the H.C. Wainwright Bioconnect Virtual Conference...
Bloom Health Partners Announces New Facilities to Serve New York and Northeastern US Regional Clients
New Bloom location will serve as a hub on the Eastern Seaboard to provide operational health services to wide array...
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory
Red Light Holland and CCrest Laboratories continue to demonstrate their strong commitment to the highest regulatory Health Canada compliance standards,...
CENTR Continues to Expand Retail Availability Across the U.S.
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
FDA Grants Breakthrough Device Designation to JelikaLite
Pilot study data suggests that JelikaLite’s Cognium medical device reduces symptoms of autism in young children and improves the quality...
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Quarterly revenue exceeds $50 million for the first time IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company...
NeonMind to Present at H.C. Wainwright Bioconnect Conference
VANCOUVER, BC / ACCESSWIRE / January 6, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug...
Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
GENEVA, SWITZERLAND / ACCESSWIRE / January 6, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a...